Literature DB >> 23282346

Infectious disease: TB's revenge.

Leigh Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23282346     DOI： 10.1038/493014a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Totally drug-resistant tuberculosis in India.

Authors:  Zarir F Udwadia; Rohit A Amale; Kanchan K Ajbani; Camilla Rodrigues
Journal:  Clin Infect Dis       Date:  2011-12-21       Impact factor: 9.079

2.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

3.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962
  3 in total
  20 in total

1.  Resistant TB: Remove cultural barriers.

Authors:  Gilles Guerrier
Journal:  Nature       Date:  2013-02-14       Impact factor: 49.962

2.  Resistant TB: Use the tools available.

Authors:  Agnes Binagwaho
Journal:  Nature       Date:  2013-02-14       Impact factor: 49.962

3.  Iron Acquisition in Mycobacterium tuberculosis.

Authors:  Alex Chao; Paul J Sieminski; Cedric P Owens; Celia W Goulding
Journal:  Chem Rev       Date:  2018-11-26       Impact factor: 60.622

4.  A novel molecule with notable activity against multi-drug resistant tuberculosis.

Authors:  Vasu Nair; Maurice O Okello; Naveen K Mangu; Byung I Seo; Machhindra G Gund
Journal:  Bioorg Med Chem Lett       Date:  2015-01-28       Impact factor: 2.823

5.  Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45.

Authors:  Yoshimasa Ishizaki; Chigusa Hayashi; Kunio Inoue; Masayuki Igarashi; Yoshiaki Takahashi; Venugopal Pujari; Dean C Crick; Patrick J Brennan; Akio Nomoto
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

6.  Glyconanomaterials for Combating Bacterial Infections.

Authors:  Olof Ramström; Mingdi Yan
Journal:  Chemistry       Date:  2015-09-29       Impact factor: 5.236

7.  Synthesis and Structure-Activity Relationship Study of Antimicrobial Auranofin against ESKAPE Pathogens.

Authors:  Bin Wu; Xiaojian Yang; Mingdi Yan
Journal:  J Med Chem       Date:  2019-08-21       Impact factor: 7.446

8.  Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection.

Authors:  Noton K Dutta; James McLachlan; Smriti Mehra; Deepak Kaushal
Journal:  Trials Vaccinol       Date:  2014-03-13

9.  Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.

Authors:  Anil Koul; Luc Vranckx; Neeraj Dhar; Hinrich W H Göhlmann; Emre Özdemir; Jean-Marc Neefs; Melanie Schulz; Ping Lu; Ejvind Mørtz; John D McKinney; Koen Andries; Dirk Bald
Journal:  Nat Commun       Date:  2014-02-26       Impact factor: 14.919

10.  Rv2969c, essential for optimal growth in Mycobacterium tuberculosis, is a DsbA-like enzyme that interacts with VKOR-derived peptides and has atypical features of DsbA-like disulfide oxidases.

Authors:  Lakshmanane Premkumar; Begoña Heras; Wilko Duprez; Patricia Walden; Maria Halili; Fabian Kurth; David P Fairlie; Jennifer L Martin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.